RNA Capital Advisors is a premier strategic and valuation advisory firm dedicated to companies and investors targeting innovation in healthcare through technology. Our primary areas of industry coverage are biopharmaceuticals, diagnostics, medical devices, digital health and technology-enabled healthcare delivery. Our senior executives have completed over 1,000 engagements representing well over $50 billion in asset and investment value. Our approach to providing our advisory services is to leverage our backgrounds in how capital markets actually work with the requisite industry understanding to help develop credible and representative portrayals of value. This core skillset allows us to be recognized as rising leaders in forecasting, complex valuation, decision analysis, disputes and transaction advisory situations.